ARTICLE
|
doi:10.20944/preprints202405.1426.v1
Subject:
Biology And Life Sciences,
Neuroscience And Neurology
Keywords:
glioblastoma (GBM); recurrent mechanism; bevacizumab (BVZ); E2F family
Online: 22 May 2024 (08:30:26 CEST)
REVIEW
|
doi:10.20944/preprints202403.1011.v1
Subject:
Biology And Life Sciences,
Biology And Biotechnology
Keywords:
retinoblastoma; RB1; E2F; Targeted Therapy; Therapeutic Vulnerabilities; Spliceosome; Cell Cycle; Epigenetic Regulators; Ubiquitin-Proteasome Pathway
Online: 18 March 2024 (10:29:38 CET)